Olfactory ligands

US2018271089A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2018271089-A1
Application numberUS-201515542097-A
CountryUS
Kind codeA1
Filing dateDec 23, 2015
Priority dateJan 9, 2015
Publication dateSep 27, 2018
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides analogues of (S)-germacrene D analogue which have improved insect repellent properties compared to (S)-germacrene D analogue or which have insect attractant properties.

First claim

Opening claim text (preview).

1 . A (S)-germacrene D analogue of general formula (I): wherein R 1 is H, methyl, ethyl, n-propyl, iso-propyl or cyclopropyl; R 2 is H, methyl, ethyl, n-propyl, iso-propyl or cyclopropyl; R 3 is methyl, ethyl, n-propyl, iso-propyl or cyclopropyl; R 4 is H, methyl, ethyl, n-propyl, iso-propyl or cyclopropyl; R 5 is H, methyl, ethyl, n-propyl, iso-propyl or cyclopropyl. 2 . The compound according to claim 1 wherein, independently or in any combination: R 1 is H, methyl or ethyl; R 2 is H, methyl or ethyl; R 3 is methyl or ethyl; R 4 is H, methyl or ethyl; R 5 is H, methyl or ethyl. 3 . The compound according to claim 1 wherein: each of R 1 , R 2 and R 4 is H; R 3 is methyl, ethyl, n-propyl, iso-propyl or cyclopropyl; and R 5 is H, methyl, ethyl, n-propyl, iso-propyl or cyclopropyl. 4 . The compound according to claim 3 wherein R 5 is H. 5 . The compound according to claim 4 which is (S)-15-methylgermacrene D. 6 . The compound according to claim 1 wherein each of R 2 , R 3 and R 5 is independently methyl, ethyl, n-propyl, iso-propyl or cyclopropyl and each of R 1 and R 4 is H; 7 . The compound according to claim 6 wherein R 5 is H. 8 . The compound according to claim 7 which is ((S)-14,15-dimethylgermacrene D. 9 . The process for the preparation of a compound according to claim 1 , the process comprising incubating a farnesyl diphosphate analogue of general formula (II): wherein R 1 , R 2 , R 3 , R 4 and R 5 are as defined in general formula (I); or a salt thereof; with germacrene D synthase (GDS). 10 . The process according to claim 9 wherein the germacrene D synthase is a recombinant (S)-germacrene D synthase polypeptide. 11 . The process according to claim 10 wherein the recombinant GDS comprises a tag sequence at the N- or C-terminus, in particular a polyhistidine tag. 12 . The process according to claim 11 wherein the GDS comprises a C-terminal polyhistidine tag, for example a hexahistidine tag. 13 . The process according to claim 9 wherein the GDS is native germacrene D synthase from Solidago canadensis SEQ ID NO: 1. 14 . The process according to claim 9 wherein the GDS is native germacrene D synthase from Solidago canadensis SEQ ID NO: 1, which has one or more of the modifications: tyrosine residue at position 406 replaced by phenylalanine, leucine, isoleucine, valine or alanine; tryptophan residue at position 275 replaced by phenylalanine, leucine, isoleucine, valine or alanine, but especially by phenylalanine; tyrosine residue at position 524 replaced by phenylalanine, leucine, isoleucine, valine or alanine, but especially by phenylalanine. 15 . The process according to claim 14 wherein the GDS has one or more of tyrosine at position 406, tryptophan at position 275 tyrosine at position 524 replaced by phenylalanine. 16 . A modified GDS polypeptide comprising a native germacrene D synthase from Solidago canadensis SEQ ID NO: 1, which has one or more of the modifications: tyrosine residue at position 406 replaced by phenylalanine, leucine, isoleucine, valine or alanine; tryptophan residue at position 275 replaced by phenylalanine, leucine, isoleucine, valine or alanine, but especially by phenylalanine; tyrosine residue at position 524 replaced by phenylalanine, leucine, isoleucine, valine or alanine, but especially by phenylalanine. 17 . The modified GDS polypeptide according to claim 16 wherein the GDS has one or more of tyrosine at position 406, tryptophan at position 275 tyrosine at position 524 replaced by phenylalanine. 18 . A nucleic acid sequence encoding the modified GDS polypeptide according to claim 16 . 19 . A vector comprising the nucleic acid sequence according to claim 18 . 20 . A cell transfected or transformed with the nucleic acid molecule according to claim 18 . 21 . An insect repellent composition comprising the compound according to claim 1 and a suitable carrier, provided that the compound of general formula (I) is not (S)-14,15-dimethylgermacrene D. 22 . The insect repellent composition according to claim 21 including the compound of general formula (I) wherein: each of R 1 , R 2 and R 4 is H; R 3 is methyl, ethyl, n-propyl, iso-propyl or cyclopropyl; and R 5 is H, methyl, ethyl, n-propyl, iso-propyl or cyclopropyl. 23 . The insect repellent composition according to claim 21 further comprising one or more addition insect repelling compounds selected from the group consisting of allethrins, DEET (N,N-diethyl-m-toluamide), p-menthane-3,8-diol (PMD), picaridin, Bayrepel, KBR 3023, Nepetalactone, Citronella oil, Neem oil, Bog Myrtle, Dimethyl carbate, Tricyclodecenyl allyl ether, IR3535 (3-[N-Butyl-N-acetyl]-aminopropionic acid, ethyl ester) or anthranilate-based insect repellents. 24 . The insect repellent composition according to claim 21 comprising a carrier suitable for application to human or animals. 25 . An insect attractant composition comprising a compound according to claim 1 and a suitable carrier, provided that the compound is not (S)-15-methylgermacrene D. 26 . The insect attractant composition according to claim 25 wherein the compound of general formula (I) is (S)-14,15-dimethylgermacrene D. 27 . The insect attractant composition according to claim 25 further comprising an insecticide. 28 . The insect attractant composition according to claim 25 further comprising a controlled release medium selected from the group consisting of rubber, polythene, hollow fibres, plastic sandwiches, plastic membranes and cellulosic materials, so that the attractant is released over a period of days at a concentration effective to attract insects. 29 . An insect trapping device comprising an insect attractant composition according to claim 25 . 30 . (canceled) 31 . A method of repelling insects comprising providing an insect repellent composition according to claim 21 in an area affected by insect infestation. 32 . A method of attracting insects comprising providing an insect attractant composition according to claim 25 in an area affected by insect infestation. 33 . A cell transfected or transformed with the vector according to claim 19 .

Assignees

Inventors

Classifications

  • with a ring being at least seven-membered · CPC title

  • cyclic (compounds containing at least three condensed carbocyclic rings C12P15/00) · CPC title

  • with a nine- to ten- membered ring · CPC title

  • Lyases (4.) · CPC title

  • A01N27/00Primary

    Biocides, pest repellants or attractants, or plant growth regulators containing hydrocarbons · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2018271089A1 cover?
The invention provides analogues of (S)-germacrene D analogue which have improved insect repellent properties compared to (S)-germacrene D analogue or which have insect attractant properties.
Who is the assignee on this patent?
Univ College Cardiff Consultants Ltd, Rothamsted Res
What technology area does this patent fall under?
Primary CPC classification A01N27/00. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Sep 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).